FibroGen, Inc.
NASDAQ:FGEN
0.58 (USD) • At close December 27, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||||
Current Assets: | ||||||||||||
Cash & Cash Equivalents
| 113.688 | 155.7 | 171.223 | 678.393 | 126.266 | 89.258 | 673.658 | 173.782 | 153.324 | 165.455 | 76.332 | 38.872 |
Short Term Investments
| 121.898 | 266.308 | 233.967 | 8.144 | 407.491 | 532.144 | 62.06 | 79.397 | 27.847 | 14.364 | 46.477 | 1.017 |
Cash and Short Term Investments
| 235.586 | 422.008 | 405.19 | 686.537 | 533.757 | 621.402 | 735.718 | 253.179 | 181.171 | 179.819 | 122.809 | 39.889 |
Net Receivables
| 41.053 | 16.299 | 25.401 | 41.883 | 153.665 | 63.684 | 8.452 | 10.448 | 15.405 | 13.453 | 17.495 | 8.784 |
Inventory
| 41.565 | 40.436 | 31.015 | 16.53 | 6.887 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 13.355 | 14.083 | 12.453 | 10.16 | 8.181 | 7.634 | 9.6 | 5.778 | 7.976 | 9.932 | 3.339 | 4.13 |
Total Current Assets
| 331.559 | 492.826 | 474.059 | 755.11 | 702.49 | 690.015 | 748.97 | 266.516 | 200.564 | 198.238 | 143.643 | 52.803 |
Non-Current Assets: | ||||||||||||
Property, Plant & Equipment, Net
| 81.372 | 100.498 | 120.15 | 63.253 | 82.345 | 127.198 | 129.476 | 123.657 | 129.02 | 132.171 | 129.898 | 123.664 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 5.29 | 9.409 | 171.621 | 2.972 | 61.118 | 55.82 | 10.506 | 71.01 | 131.72 | 144.269 | 15.356 | 81.613 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 5.308 | 7.354 | 7.991 | 5.505 | 11.444 | 7.565 | 9.698 | 8.369 | 9.27 | 8.85 | 8.055 | 7.508 |
Total Non-Current Assets
| 91.97 | 117.261 | 299.762 | 71.73 | 154.907 | 190.583 | 149.68 | 203.036 | 270.01 | 285.29 | 153.309 | 212.785 |
Total Assets
| 423.529 | 610.087 | 773.821 | 826.84 | 857.397 | 880.598 | 898.65 | 469.552 | 470.574 | 483.528 | 296.952 | 265.588 |
Liabilities & Equity: | ||||||||||||
Current Liabilities: | ||||||||||||
Account Payables
| 17.96 | 30.758 | 26.097 | 24.789 | 6.088 | 9.139 | 5.509 | 6.223 | 6.521 | 4.551 | 1.066 | 3.107 |
Short Term Debt
| 14.077 | 10.328 | 21.91 | 13.518 | 13.334 | 0 | 0 | 0 | 0 | 0.403 | 0.403 | 0.732 |
Tax Payables
| 6.615 | 7.691 | 12.61 | 5.97 | 2.044 | 1.095 | 4.201 | 0 | 0 | 0.779 | 0.059 | 0.186 |
Deferred Revenue
| 12.74 | 13.129 | 15.857 | 6.547 | 0.49 | 13.771 | 7.968 | 7.988 | 12.728 | 9.218 | 5.741 | 2.393 |
Other Current Liabilities
| 166.236 | 224.785 | 149.023 | 118.91 | 81.772 | 65.028 | 76.25 | 50.914 | 47.932 | 47.803 | 30.21 | 17.26 |
Total Current Liabilities
| 217.668 | 273.562 | 225.497 | 163.187 | 102.745 | 89.033 | 77.258 | 65.125 | 67.181 | 62.754 | 37.479 | 23.678 |
Non-Current Liabilities: | ||||||||||||
Long Term Debt
| 156.338 | 79.593 | 88.779 | 26.244 | 38.552 | 97.157 | 97.763 | 97.352 | 97.042 | 96.818 | 115.263 | 86.69 |
Deferred Revenue Non-Current
| 157.555 | 185.722 | 186.801 | 138.474 | 99.449 | 136.109 | 112.231 | 106.709 | 85.132 | 60.988 | 30.908 | 3.371 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 3.038 | 3.657 | 4.212 | 4.702 | 5.131 | 5.503 | 5.809 |
Other Non-Current Liabilities
| 54.167 | 72.69 | 43.631 | 57.486 | 81.245 | 29.829 | 167.189 | 25.257 | 24.394 | 22.292 | 31.104 | 12.238 |
Total Non-Current Liabilities
| 368.06 | 338.005 | 319.211 | 222.204 | 219.246 | 263.095 | 238.942 | 229.318 | 206.568 | 180.098 | 151.87 | 119.726 |
Total Liabilities
| 585.728 | 611.567 | 544.708 | 385.391 | 321.991 | 352.128 | 316.2 | 294.443 | 273.749 | 242.852 | 189.349 | 143.404 |
Equity: | ||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 483.528 | 304.749 | 304.749 |
Common Stock
| 0.988 | 0.942 | 0.929 | 0.914 | 0.877 | 0.854 | 0.825 | 0.637 | 0.62 | 0.59 | 0.132 | 0.132 |
Retained Earnings
| -1,841.92 | -1,557.688 | -1,264.034 | -974.011 | -784.72 | -715.827 | -595.945 | -469.742 | -408.062 | -322.283 | -262.779 | -247.836 |
Accumulated Other Comprehensive Income/Loss
| -6.875 | -5.72 | -4.163 | -4.499 | -0.747 | -2.281 | -1.795 | -0.96 | -1.651 | -3.149 | -3.508 | -0.167 |
Other Total Stockholders Equity
| 1,643.641 | 1,541.019 | 1,476.414 | 1,399.774 | 1,300.725 | 1,226.453 | 1,160.094 | 625.903 | 586.647 | 546.247 | 41.134 | 37.606 |
Total Shareholders Equity
| -204.166 | -21.447 | 209.146 | 422.178 | 516.135 | 509.199 | 563.179 | 155.838 | 177.554 | 221.405 | 79.728 | 94.484 |
Total Equity
| -162.199 | -1.48 | 229.113 | 441.449 | 535.406 | 528.47 | 582.45 | 175.109 | 196.825 | 240.676 | 107.603 | 122.184 |
Total Liabilities & Shareholders Equity
| 423.529 | 610.087 | 773.821 | 826.84 | 857.397 | 880.598 | 898.65 | 469.552 | 470.574 | 483.528 | 296.952 | 265.588 |